Natera (NTRA) Change in Accured Expenses (2014 - 2026)
Natera's (NTRA) quarterly Change in Accured Expenses came in at -$39.3 million in Q2 2026, down 389.26% on a YoY basis from $13.6 million in Q2 2025, and down 140.04% quarter-over-quarter from $98.2 million in Q1 2026.
Analysis
Natera (NTRA) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported Change in Accured Expenses for 13 consecutive years, with -$39.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Accured Expenses fell 389.26% year-over-year to -$39.3 million; the trailing twelve-month figure through Jun 2026 stood at $78.7 million (up 28.83% YoY), and the FY2025 full-year result was $60.3 million, up 49.45% from the prior year.
- Change in Accured Expenses slipped to -$39.3 million in Q2 2026 per NTRA's latest filing, from $98.2 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $98.2 million in Q1 2026 and bottomed at -$39.3 million in Q2 2026.
- Historically, Change in Accured Expenses has averaged $12.7 million across 5 years, with a median of $10.1 million in 2022.
- The sharpest annual moves came in 2022 and 2026: Change in Accured Expenses jumped 665.33% in 2022, then slumped 389.26% in 2026.
- Over 5 years, Change in Accured Expenses stood at $12.2 million in 2022, then tumbled by 47.32% to $6.4 million in 2023, then surged by 102.78% to $13.1 million in 2024, then fell by 7.61% to $12.1 million in 2025, then slumped by 425.91% to -$39.3 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$39.3 million, $98.2 million, and $12.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | -39.33 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 142.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | -24.00 Mn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 44.29 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 14.68 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 25.08 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | -205,000.00 |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 821,000.00 |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 1.01 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -39.33 Mn |
| Mar 31, 2026 | 98.23 Mn |
| Dec 31, 2025 | 12.07 Mn |
| Sep 30, 2025 | 7.74 Mn |
| Jun 30, 2025 | 13.60 Mn |
| Mar 31, 2025 | 26.87 Mn |
| Dec 31, 2024 | 13.06 Mn |
| Sep 30, 2024 | 7.56 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 17.79 Mn |
| Dec 31, 2023 | 6.44 Mn |
| Sep 30, 2023 | 26.35 Mn |
| Jun 30, 2023 | 7.01 Mn |
| Mar 31, 2023 | -18.18 Mn |
| Dec 31, 2022 | 12.23 Mn |
| Sep 30, 2022 | 5.90 Mn |
| Jun 30, 2022 | 8.19 Mn |
| Mar 31, 2022 | 21.34 Mn |
| Dec 31, 2021 | -2.16 Mn |
| Sep 30, 2021 | 10.47 Mn |